🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsTRIUMPH program trial design overview — all Phase 3 arms Page 4

TRIUMPH program trial design overview — all Phase 3 arms

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 324 replies 45,778 viewsPage 4 of 20
tommy_boulder
Member
234
1,123
Nov 2024
Boulder, CO
Mar 4, 2024 at 5:42 PM#16
Dr.PainCLE said:
The useful move here is to separate what is established from what is widely repeated.

This matches mine closely enough to be worth saying so out loud.

Last edited: Mar 4, 2024 at 6:42 PM
27 2paul_denver, TinaHashiRN, robert_kc and 24 others
Reply Quote Save Share Report
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Mar 5, 2024 at 3:45 PM#17
HPLC_Greg said:
A quick sanity check on any figure quoted here: is it mean or median, is it intention-to-treat or completers, and what was the comparator.

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

26 1SleepFixSam, PurityPaulOR, MaxMetOK and 23 others
Reply Quote Save Share Report
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Mar 6, 2024 at 1:47 PM#18
HPLC_Greg said:
A quick sanity check on any figure quoted here: is it mean or median, is it intention-to-treat or completers, and what was the comparator.

True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.

25 0james_edin, FranDenver, Dr.BariatricHTX and 22 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Mar 7, 2024 at 11:49 AM#19
HPLC_Greg said:
A quick sanity check on any figure quoted here: is it mean or median, is it intention-to-treat or completers, and what was the comparator.

That reframing is the part I needed. Sending this to two other people who asked me the same thing last week.

Last edited: Mar 7, 2024 at 5:49 PM
24 24Dr.PainCLE, mike_mealprep, NicoleRaleigh and 21 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 8, 2024 at 9:50 AM#20

Moderator note: a couple of off-topic posts removed. Thread quality here is what the rules are for. Keep it up.

2 2PeptideSynthNJ, Dr.KarenChen
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register